Johnson & Johnson (JNJ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2008 | 03-2008 | 12-2007 | 09-2007 | 06-2007 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 6,925,000 | 3,598,000 | 10,576,000 | 8,202,000 | 5,654,000 |
| Depreciation Amortization | 1,349,000 | 666,000 | 2,777,000 | 1,902,000 | 1,305,000 |
| Income taxes - deferred | -322,000 | -27,000 | -1,762,000 | -900,000 | -405,000 |
| Accounts receivable | -717,000 | -505,000 | -394,000 | -394,000 | -658,000 |
| Other Working Capital | -2,270,000 | -1,164,000 | 1,248,000 | 377,000 | -987,000 |
| Other Operating Activity | 1,113,000 | 668,000 | 2,577,000 | 1,738,000 | 1,825,000 |
| Operating Cash Flow | $6,078,000 | $3,236,000 | $15,022,000 | $10,925,000 | $6,734,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,119,000 | -445,000 | -2,485,000 | -1,490,000 | -831,000 |
| Net Acquisitions | -46,000 | -8,000 | -1,388,000 | -1,378,000 | -1,368,000 |
| Purchase Of Investment | -687,000 | -436,000 | -9,659,000 | -8,475,000 | -566,000 |
| Sale Of Investment | 1,786,000 | 1,363,000 | 7,988,000 | 6,706,000 | 103,000 |
| Other Investing Activity | -46,000 | -22,000 | -368,000 | -101,000 | -49,000 |
| Investing Cash Flow | $-112,000 | $452,000 | $-5,912,000 | $-4,738,000 | $-2,711,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 3,376,000 | 2,037,000 | 19,626,000 | 20,124,000 | 15,296,000 |
| Debt Issued | 1,641,000 | N/A | 5,100,000 | 2,605,000 | 1,000 |
| Debt Repayment | -5,000 | -2,000 | -18,000 | -12,000 | -6,000 |
| Common Stock Issued | 610,000 | 256,000 | 1,562,000 | 961,000 | 564,000 |
| Common Stock Repurchased | -3,617,000 | -1,779,000 | -5,607,000 | -2,581,000 | -739,000 |
| Dividend Paid | -2,466,000 | -1,174,000 | -4,670,000 | -3,486,000 | -2,287,000 |
| Other Financing Activity | -837,000 | -448,000 | -21,691,000 | -21,461,000 | -15,449,000 |
| Financing Cash Flow | $-1,298,000 | $-1,110,000 | $-5,698,000 | $-3,850,000 | $-2,620,000 |
| Exchange Rate Effect | 208,000 | 191,000 | 275,000 | 220,000 | 85,000 |
| Beginning Cash Position | 7,770,000 | 7,770,000 | 4,083,000 | 4,083,000 | 4,083,000 |
| End Cash Position | 12,646,000 | 10,539,000 | 7,770,000 | 6,640,000 | 5,571,000 |
| Net Cash Flow | $4,876,000 | $2,769,000 | $3,687,000 | $2,557,000 | $1,488,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 6,078,000 | 3,236,000 | 15,022,000 | 10,925,000 | 6,734,000 |
| Capital Expenditure | -1,166,000 | -479,000 | -2,942,000 | -1,704,000 | -1,045,000 |
| Free Cash Flow | 4,912,000 | 2,757,000 | 12,080,000 | 9,221,000 | 5,689,000 |